IP Library Granted Patent US 12,465,736
Granted Patent B2
US 12,465,736 · App. 17/269,120 · Granted Nov 11, 2025

Device comprising microneedles for in-situ reaction of a skin

Inventors: Veronique Burnier (Chevilly-la-Rue, FR); Dominique Bordeaux (Chevilly-la-Rue, FR)
Assignee: L'OREAL
A61M37/0015A61M2037/0023A61M2037/003A61M2037/0046A61M2037/0061
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,465,736
App. No.
17/269,120
Granted
Nov 11, 2025
Kind
B2
Abstract

A device including a base carrying a plurality of microneedles, and including at least one composition aimed at generating an in-situ reaction into the skin, scalp, or lips.

Claims (27)

1 . A device comprising a base carrying a plurality of microneedles, wherein the device includes at least one composition that generates an in-situ reaction into the skin, scalp, or lips in order to correct, supply volume, soften and/or erase skin aging signs disorders, wherein:

the in-situ reaction transforms the at least one composition by increasing viscosity of the least one composition by binding, cross-linking, reticulation, gelification, precipitation, aggregation, association, bounding, or mixing at a time between preparation of the at least one composition and up to post-injection into the skin, scalp, or lips.

2 . The device of claim 1 , wherein the microneedles are hollow.

3 . The device of claim 1 , wherein the microneedles are solid.

4 . The device of claim 1 , wherein the microneedles are resorbable.

5 . The device of the claim 4 , wherein the microneedles are swellable.

6 . The device of claim 1 , wherein the microneedles are non-resorbable.

7 . The device of claim 1 , wherein the microneedles are made in a porous material.

8 . The device of claim 1 , wherein a length of each microneedle is less than or equal to 50 mm.

9 . The device of claim 1 , wherein each hollow microneedle has an internal volume that is less than or equal to 10 mm 3 .

10 . The device of claim 1 , wherein the microneedles are configured to deliver the composition at a flow rate less than or equal to 3 cm 3 /min.

11 . The device of claim 1 , wherein each microneedle comprises a stop configured for limiting the depth of injection of the microneedle into the skin to less than or equal to 500 micrometers.

12 . The device of claim 1 , wherein an external largest transverse dimension of each microneedle is less than or equal to 1500 micrometers.

13 . The device of claim 1 , wherein the composition is a fluid composition containing at least one material in the dispersed state in a liquid medium, said composition being solidifiable via the reaction of said material into the skin, scalp, or lips.

14 . The device of claim 1 , wherein the composition comprises at least one bio-polymer, and an ion solution.

15 . The device of claim 1 , wherein the microneedles are hollow and resorbable, at least part of the material in which are made the microneedles being used, once injected into the skin, scalp or lips, to generate the in-situ reaction by reacting with a composition delivered by the microneedles, the composition delivered by the microneedles comprising an alginate.

16 . A kit comprising a device such as defined in claim 1 and one or several compositions aimed at generating an in-situ reaction into the skin, scalp, or lips.

17 . A method for preparing an injection of a composition aimed at generating an in-situ reaction into an area of skin, scalp, or lips for correcting a relief or appearance of this area, the injection being performed with the device as defined in claim 1 , the method comprising:

performing an acquisition of the topography of the area, and

based on such acquisition of the topography, computing a volume of composition to inject into the skin, scalp, or lips via each microneedle.

18 . The method of claim 17 , wherein the computing of the volume of composition to inject further depends on the properties of reaction of the composition.

19 . The method of claim 17 , wherein the composition comprises at least one bio-polymer and an ion solution, the latter being mixed before their injection in hollow microneedles.

20 . The method of claim 17 , wherein the composition comprises at least one bio-polymer and an ion solution, the latter being stored in different containers and separately injected in hollow microneedles.

21 . The device of claim 2 , wherein the microneedles are resorbable.

22 . The device of the claim 21 , wherein the microneedles are swellable.

23 . The device of the claim 15 , wherein the material in which are made the microneedles comprises a carbonate solution.

24 . The method of claim 20 , wherein said at least one bio-polymer and ion solution are stored in different containers with a ratio of 50% each.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 15, 2021
From: BURNIER, VERONIQUE; BORDEAUX, DOMINIQUE
To: L'OREAL
Reel/Frame 056863/0307 →
Continuity (1)
Related Publication 20210322744A1 · Oct 21, 2021
References Cited (61)
US 5879326A · Godshall et al. · 1999 [cited by applicant]
US 6503231B1 · Prausnitz et al. · 2003 [cited by applicant]
US 6565532B1 · Yuzhakov et al. · 2003 [cited by applicant]
US 9302903B2 · Park et al. · 2016 [cited by applicant]
US 20020082543A1 · Park et al. · 2002 [cited by applicant]
US 20040223985A1 · Dunfield · 2004 [cited by examiner]
US 20090088686A1 · Cook · 2009 [cited by applicant]
US 20090110731A1 · Fritz et al. · 2009 [cited by applicant]
US 20090182306A1 · Lee et al. · 2009 [cited by applicant]
US 20100049178A1 · Deem et al. · 2010 [cited by applicant]
US 20100228203A1 · Quan et al. · 2010 [cited by applicant]
US 20110213335A1 · Burton et al. · 2011 [cited by applicant]
US 20110230736A1 · Tepper et al. · 2011 [cited by applicant]
US 20120116305A1 · Papp · 2012 [cited by examiner]
US 20130116523A1 · Jung et al. · 2013 [cited by applicant]
US 20140200508A1 · Cohen · 2014 [cited by examiner]
US 20140200509A1 · Cohen et al. · 2014 [cited by applicant]
US 20150141910A1 · Francis · 2015 [cited by examiner]
US 20160000898A1 · Machida · 2016 [cited by examiner]
US 20170050010A1 · Mcallister et al. · 2017 [cited by applicant]
US 20180289856A1 · Huang · 2018 [cited by examiner]
US 20210060321A1 · Amir · 2021 [cited by applicant]
EP 542669A1 · 1993 [cited by applicant]
EP 787730A1 · 1997 [cited by applicant]
EP 787731A2 · 1997 [cited by applicant]
EP 2876602A1 · 2015 [cited by applicant]
EP 3144030A1 · 2017 [cited by applicant]
JP 2015205094A · 2015 [cited by applicant]
WO 199608537A1 · 1996 [cited by applicant]
WO 2005123172A1 · 2005 [cited by applicant]
WO 2008072229A2 · 2008 [cited by applicant]
WO 2009040548A1 · 2009 [cited by applicant]
WO 2014027055A2 · 2014 [cited by applicant]
WO 2014041531A1 · 2014 [cited by applicant]
WO 2016076442A1 · 2016 [cited by applicant]
WO 2017019526A2 · 2017 [cited by applicant]
Restriction Requirement issued for U.S. Appl. No. 17/269,131, mailed Jan. 12, 2024 (8 pages). [cited by applicant]
(Abstract) Niclas Roxhed et al., “Membrane-sealed hollow microneedles and related administration schemes for transdermal drug delivery”, Biomed Microdevices, vol. 10 (2): 271-279, Apr. 2008. [cited by applicant]
https://web.archive.org/web/20160319074846/http:/www.3m.com/3M/en_US/drug-delivery-systems-us/technologies/microneedle (2015); accessed Sep. 2, 2021. [cited by applicant]
Daugimont et al., “Hollow Microneedle Arrays for Intradermal Drug Delivery and DNA Electroporation”, J. Membrane Biol., vol. 236 (1): 117-125, Jul. 2010. [cited by applicant]
Ita, “Transdermal Delivery of Drugs with Microneedles—Potential and Challenges”, Pharmaceutics, vol. 7 (3): 90-105, Jun. 2015. [cited by applicant]
Larsen et al., “Rheological characterization of an injectable alginate gel system”, BMC Biotechnology vol. 15 (29):1-12, May 2015. [cited by applicant]
Mcallister et al., “Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: Fabrication methods and transport studies”, PNAS, vol. 100 (24): 13755-13760, Nov. 2003. [cited by applicant]
Mukerjee et al., “Microneedle array for transdermal biological fluid extraction and in situ analysis”, Sensors and Actuators A, vol. 114 (2-3): 267-275, Sep. 2004. [cited by applicant]
O'Mahony, “Structural characterization and in-vivo reliability evaluation of silicon microneedles”, vol. 16 (3): 333-343, Feb. 2014. [cited by applicant]
Park et al., “Biodegradable polymer microneedles: Fabrication, mechanics and transdermal drug delivery”, Journal of Controlled Release, vol. 104 (1): 51-66, May 2005. [cited by applicant]
Perennes et al., “Sharp beveled tip hollow microneedle arrays fabricated by LIGA and 3D soft lithography with polyvinyl alcohol”, Journal of Micromechanics and Microengineering, vol. 16 (3): 473-479, Jan. 2006. [cited by applicant]
Prausnitz et al., “Microneedles for transdermal drug delivery”, Advanced Drug Delivery Reviews, vol. 56 (5): 581-587, Mar. 2004. [cited by applicant]
Lhernould, “Optimizing hollow microneedles arrays aimed at transdermal drug delivery”, Microsystem Technologies, vol. 19, 1-8, Jan. 2013. [cited by applicant]
Tyndall National Institute—Transdermal Drug Delivery—Microneedle Technologies for Transdermal Delivery (undated). [cited by applicant]
Non-Final Office Action i(NFOA) issued for U.S. Appl. No. 17/269,111, mailed Mar. 15, 2024 (22 pages). [cited by applicant]
International Search Report (ISR) for PCT/EP2018/075793 mailed Jun. 25, 2019 ( 5 pages). [cited by applicant]
Written Opinion for PCT/EP2018/075793 mailed Jun. 25, 2019 (8 pages). [cited by applicant]
International Search Report (ISR) for PCT/EP2018/075796 mailed Jun. 25, 2019 ( 4 pages). [cited by applicant]
Written Opinion for PCT/EP2018/075796 mailed Jun. 25, 2019 (6 pages). [cited by applicant]
International Search Report (ISR) for PCT/EP2018/075800 mailed Jun. 25, 2019 ( 4 pages). [cited by applicant]
Written Opinion for PCT/EP2018/075800 mailed Jun. 25, 2019 (7 pages). [cited by applicant]
Non-Final Office Action (NFOA) issued for U.S. Appl. No. 17/269,131, mailed Jun. 20, 2024 (15 pages). [cited by applicant]
Final Rejection issued for U.S. Appl. No. 17/269,131, mailed Oct. 1, 2024 (12 pages). [cited by applicant]
Non-Final Office Action (NFOA) issued for U.S. Appl. No. 17/269,131, mailed Feb. 12, 2025 (13 pages). [cited by applicant]
Office Action for U.S. Appl. No. 17/269,131 dated Jul. 29, 2025. [cited by applicant]